Colossal Biosciences INC.

Biotechnology and genetic engineering company.

Based in TX

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $360K in lobbying spend across 7 quarterly filings, Colossal Biosciences INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2024 to 2025.

$360K
Total Spend
2
Years Active
1
Firms Hired
8
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2024$120K
2025$240K

Issues Lobbied

AnimalsScience/Technology

Lobbying Firms

Atlas Crossing LLC

Lobbyists

Alexis ObergChristopher KimTimothy MonahanSean JoyceChristopher EddowesChristopher SweetAlex BoltonJennifer Belair

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Animals, Science/Technology

  • •Issues related to animal conservation.
  • •Issues related to wildlife conservation.
  • •Issues related to biotechnology.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Tech Lobbying
Industry overview and top spenders

Related Investigations

Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Match Group, INC.
$9.9M total spend
Ut Southwestern Medical Center
$3.5M total spend
Qorvo
$2.6M total spend
Axiom Space, INC.
$2.5M total spend
Southwest Airlines Pilots' Association
$2.3M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.